Lifevantage Corp (LFVN)

Pharmaceutical Preparations

Latest Price

$5.88

TTM P/E

12.78

Normalized P/E

18.00

TTM Div Yield

3.15%

Fwd Div Yield

3.15%

Book Value

2.61

P/B Ratio

2.26

Valuation metrics

EPS: $0.40

Book value / share: $2.68

Formula: √(22.5 × EPS × BVPS)

Graham Number

$4.91

16% downside

Norm. op. income: $8M (median of 7yr)

Tax rate: 25%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$5.72

3% downside

Base FCF: $7M (median of recent 5yr)

Growth: -15%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$3.46

41% downside

EPS: $0.40

Target P/E: 18×

Formula: EPS × P/E

P/E Fair Value

$7.20

+22% upside

46.3% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
Capital Management Corp	1.88M	$11.0M	15.01%	-563.5K	2026-06-30
Renaissance Technologies LLC	669.4K	$4.0M	5.35%	-198.3K	2026-06-30
Vanguard Capital Management LLC	429.2K	$2.0M	3.43%	-219	2026-06-30
BlackRock, Inc.	268.6K	$1.0M	2.15%	-501.1K	2026-06-30
Dimensional Fund Advisors LP	256.3K	$1.0M	2.05%	-19.9K	2026-06-30
Envestnet Asset Management Inc	229.9K	$1.0M	1.84%	+10.7K	2026-06-30
Jane Street Group, LLC	203.7K	$1.0M	1.63%	+162.4K	2026-06-30
Citadel Advisors LLC	172.5K	$1.0M	1.38%	+96.0K	2026-06-30
American Century Companies Inc	144.4K	--	1.15%	+39.7K	2026-06-30
Geode Capital Management, LLC	120.8K	--	0.97%	-140.4K	2026-06-30